We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+6.7%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.05B
AUM Growth
+$218M
Cap. Flow
+$168M
Cap. Flow %
16.07%
Top 10 Hldgs %
21.03%
Holding
2,026
New
510
Increased
479
Reduced
417
Closed
552

Top Buys

Rank Stock Value
1
GTN icon
Gray Television
GTN
+$13.2M
2
CEB
CEB Inc.
CEB
+$10.9M
3
WOOF
VCA Inc.
WOOF
+$10.3M
4
TMUS icon
T-Mobile US
TMUS
+$10M
5
SBGI icon
Sinclair Inc
SBGI
+$9.59M

Sector Composition

Rank Sector Weight
1 Technology 10.55%
2 Communication Services 8.56%
3 Energy 8.43%
4 Healthcare 8.02%
5 Industrials 7.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IVC
476
DELISTED
Invacare Corporation
IVC
$244K 0.02%
20,511
+12,428
+154% +$149K
ASCMA
477
DELISTED
Ascent Capital Group, Inc. Series A
ASCMA
$244K 0.02%
17,293
+4,176
+32% +$65.8K
GRFS
478
Grifois
GRFS
$5.4B
$243K 0.02%
12,885
+5,177
+67% +$89.8K
HHH icon
479
Howard Hughes
HHH
$4.09B
$243K 0.02%
+2,171
New +$234K
MGLN
480
DELISTED
Magellan Health Services, Inc.
MGLN
$243K 0.02%
3,518
+285
+9% +$20.8K
PDLI
481
DELISTED
PDL BioPharma, Inc.
PDLI
$243K 0.02%
107,100
+33,900
+46% +$75K
OXFD
482
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$242K 0.02%
15,637
+3,100
+25% +$44.3K
PMC
483
DELISTED
PharMerica Corporation
PMC
$242K 0.02%
10,332
+6,280
+155% +$155K
SCLN
484
DELISTED
Sciclone Pharmaceuticals Inc
SCLN
$242K 0.02%
24,672
+17,527
+245% +$175K
LJPC
485
DELISTED
La Jolla Pharmaceutical Company
LJPC
$242K 0.02%
+8,096
New +$207K
ENZ
486
DELISTED
Enzo Biochem, Inc.
ENZ
$241K 0.02%
28,800
+8,700
+43% +$61.3K
AGTC
487
DELISTED
Applied Genetic Technologies Corporation
AGTC
$241K 0.02%
34,900
+23,500
+206% +$184K
FCX icon
488
Freeport-McMoran
FCX
$98.6B
$240K 0.02%
+17,984
New +$258K
GRMN
489
Garmin
GRMN
$59.1B
$240K 0.02%
+4,700
New +$237K
SCL icon
490
Stepan Co
SCL
$1.46B
$239K 0.02%
3,031
-1,612
-35% -$126K
SNEX icon
491
StoneX
SNEX
$8.03B
$239K 0.02%
31,894
+9,619
+43% +$71.3K
SEE
492
DELISTED
Sealed Air
SEE
$238K 0.02%
+5,454
New +$256K
UNP icon
493
Union Pacific
UNP
$175B
$238K 0.02%
+2,251
New +$240K
HVT icon
494
Haverty Furniture Companies
HVT
$455M
$236K 0.02%
9,700
-4,500
-32% -$103K
AFL icon
495
Aflac
AFL
$63B
$235K 0.02%
6,480
+1,398
+28% +$49.5K
IQV icon
496
IQVIA
IQV
$38.3B
$235K 0.02%
2,921
+1,310
+81% +$102K
QUAD icon
497
Quad
QUAD
$518M
$235K 0.02%
9,300
+200
+2% +$5.13K
IXYS
498
DELISTED
IXYS Corp
IXYS
$235K 0.02%
16,130
-1,400
-8% -$17.9K
JUNO
499
DELISTED
Juno Therapeutics, Inc.
JUNO
$233K 0.02%
10,500
+5,456
+108% +$117K
MS icon
500
Morgan Stanley
MS
$337B
$232K 0.02%
+5,417
New +$240K

Similar funds

Prelude Capital Management's Q1 2017 Portfolio in Review

As of Q1 2017, Prelude Capital Management held 2,026 positions worth $1.05B, up 26% from $828M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Prelude Capital Management deployed $168M of net new capital in Q1 2017, opening 510 new positions and adding to 479 existing holdings. Its largest new stake was Gray Television: 1,043,304 shares worth $15.1M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 17% a quarter earlier, followed by Communication Services and Energy.

On the sell side, the largest reduction was NetEase, an estimated $4.97M trimmed.

  • Prelude Capital Management's largest Q1 2017 buy was Gray Television: 1,043,304 shares worth $15.1M.
  • Prelude Capital Management added most to VCA Inc. in Q1 2017, an estimated $10.3M increase.
  • Prelude Capital Management's biggest Q1 2017 reduction was NetEase, cutting an estimated $4.97M.
  • Prelude Capital Management fully exited Harman International Industries in Q1 2017, selling an estimated $15.1M.
  • Prelude Capital Management's ten largest holdings make up 21% of its $1.05B portfolio in Q1 2017.
  • Prelude Capital Management opened 510 new positions and closed 552 in Q1 2017.
  • Prelude Capital Management's portfolio value rose 26% quarter-over-quarter to $1.05B.

Based on Prelude Capital Management's 13F filing for Q1 2017, filed 15 May 2017.